Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection
β Scribed by Yasuharu Ikeda; Mitsuo Shimada; Hirofumi Hasegawa; Tomonobu Gion; Kiyoshi Kajiyama; Ken Shirabe; Katsuhiko Yanaga; Kenji Takenaka; Keizo Sugimachi
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 70 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
We evaluated the effect of diabetes mellitus on the prognosis of hepatocellular carcinoma after an elective hepatic resection. Of the 342 patients who underwent a hepatic resection between April 1985 and March 1995, 87 (25.4%) were diabetic. Postoperative morbidity was more common among diabetics than among nondiabetics (36.0% vs. 22.5%, P = .0239). The postoperative survival rate and the cancer-free survival rate were also better in patients without diabetes than in those with diabetes (P = .0333, P = .0149). The results of a multivariate analysis show diabetes mellitus to be an independent and prognostic indicator after a hepatic resection with hepatocellular carcinoma. According to the above findings, diabetes mellitus is thus considered to be a risk factor for prognosis after hepatic resection in patients with hepatocellular carcinoma.
π SIMILAR VOLUMES
Recent studies suggest that diabetes mellitus increases the risk of developing hepatocellular carcinoma (HCC). The aim of this study is to quantify the risk of HCC among patients with both diabetes mellitus and hepatitis C in a large cohort of patients with chronic hepatitis C and advanced fibrosis.
## BACKGROUND. This study was performed to clarify the clinicopathologic features of hepatocellular carcinoma (HCC) patients surviving ΟΎ10 years after hepatic resection. ## METHODS. Between January 1971 and April 1987, 142 patients underwent hepatic resection. Thirty-nine patients who died of s
## Abstract ## Background and Objectives It is important to identify prognostic factors in patients with hepatocellular carcinoma (HCC) before hepatectomy. No previous studies have addressed the predictive efficacy of the preoperative doubling times of alphaβfetoprotein (AFP) and protein induced b